Search Results 801-810 of 14763 for anti-TNF drugs

1. Endoxifen Shows Promise as Breast Cancer Treatment - Mayo Clinic News Network

   A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti- ...

2. Malathion (Topical Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Pembrolizumab (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Exenatide (Subcutaneous Route) Proper Use - Mayo Clinic

   Do not use these medicines together. Byetta® comes in a prefilled pen that you will use to inject it. Each pen contains enough medicine for 60 doses. Bydureon® ...

5. Cough And Cold Combinations (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

6. Germs: Understand and protect against bacteria, viruses and infections - Mayo Clinic

   Medicines. Some medicines offer short-term protection from certain germs. For example, taking an anti-parasitic medicine might keep you from getting malaria ...

7. Tolnaftate (Topical Route) Description and Brand Names - Mayo Clinic

   Tolnaftate belongs to the group of medicines called antifungals. It is used to treat some types of fungus infections. It may also be used together with ...

8. Interferon Beta-1a (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Avonex; Avonex Pen; Rebif; Rebif Rebidose; Rebif Rebidose ...

9. CAR-T Cell Therapy Program - Overview - Mayo Clinic

   Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

10. An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma - Mayo Clinic

    Prior treatment with interferon (if complete < 6 months prior to participation in study), anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, or anti-CTLA-4 ...